Vickers secures US$200m commitments for its largest fund yet; portfolio biotechs active in Covid-19 space

Fund VI is set to be largest non-government linked venture capital fund raised by a firm based in S-E Asia

Claudia Chong

Published Fri, Mar 27, 2020 · 09:50 PM

Singapore

THE novel coronavirus pandemic has raised the potential of deep-tech investor Vickers Venture Partners' portfolio, said chairman Finian Tan, as the firm announced it has secured commitments of US$200 million for its largest fund yet.

The upcoming US$500 million Fund VI - set to be the largest non-government linked venture capital fund raised by a firm based in South-east Asia - is already invested in synthetic vaccines maker Emergex.

"We are very confident it will have a viable vaccine (for Covid-19) within 12 to 18 months," Dr Tan said on Thursday.

Another Vickers portfolio company called DrugArray, based in the US and China, …